Get started
Author

Bernard Bonvoisin

Observed names: B Bonvoisin, Bonvoisin, Bernard (1956-...)
Observed institution: F. Hoffmann-La Roche AG
OpenAlex ID: A5113564853
Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study
2005 · Paul D Miller, Michael R Mcclung, et al. · Journal of Bone and Mineral Research · 333
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study
2005 · J-Y Reginster, S Adami, et al. · Annals of the Rheumatic Diseases · 326
Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allerens in asthmatic patients a preliminary study
1987 · Philippe Guinot, Christian Brambilla, et al. · Prostaglandins · 71
Monthly Oral Ibandronate Is Well Tolerated and Efficacious in Postmenopausal Women: Results from the Monthly Oral Pilot Study
2005 · Jean-Yves Reginster, Katie M. Wilson, et al. · The Journal of Clinical Endocrinology & Metabolism · 53
PDF
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate
2005 · Jean-Yves Reginster, Dieter Felsenberg, et al. · Osteoporosis International · 40
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study
2009 · Robert R. Recker, Louis-George Ste-Marie, et al. · Bone · 32
Once-monthly oral ibandronate (Boniva) dosing is highly efficacious in postmenopausal osteoporosis: 2-year results from MOBILE
2005 · Stuart Silverman, Maria Greenwald, et al. · ORBi (University of Liège) · 1
Tolerability of monthly oral ibandronate in postmenopausal osteoporosis: 1-year results from the MOBILE Study
2004 · Robert R. Recker, Stuart L. Silverman, et al. · ORBi (University of Liège)
Antisocial
1980 · Krief, Norbert (1956-...), Bonvoisin, Bernard (1956-...)
Works count: 9
Citation count: 856
H-index: 6
I10-index: 6
Year
Topic
Type